Capricor Therapeutics
2 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✗
Capricor Therapeutics faces investor investigations and biotech sector scrutiny ahead of an anticipated August decision.
5 sources
6 articles
v 3
48d ago
◼ Archived
Business
🔮 fades ✗
FDA scientists are disputing efficacy claims regarding Capricor Therapeutics' Phase 3 Duchenne muscular dystrophy cell therapy, triggering a stock plunge.
10 sources
11 articles
v 9
48d ago
\n
\n
\n